Correlation Between GMS and CERo Therapeutics
Can any of the company-specific risk be diversified away by investing in both GMS and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GMS and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GMS Inc and CERo Therapeutics Holdings, you can compare the effects of market volatilities on GMS and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GMS with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GMS and CERo Therapeutics.
Diversification Opportunities for GMS and CERo Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between GMS and CERo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding GMS Inc and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and GMS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GMS Inc are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of GMS i.e., GMS and CERo Therapeutics go up and down completely randomly.
Pair Corralation between GMS and CERo Therapeutics
Considering the 90-day investment horizon GMS Inc is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, GMS Inc is 18.53 times less risky than CERo Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 1.04 in CERo Therapeutics Holdings on November 28, 2024 and sell it today you would earn a total of 0.12 from holding CERo Therapeutics Holdings or generate 11.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 88.52% |
| Values | Daily Returns |
GMS Inc vs. CERo Therapeutics Holdings
Performance |
| Timeline |
| GMS Inc |
| CERo Therapeutics |
GMS and CERo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GMS and CERo Therapeutics
The main advantage of trading using opposite GMS and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GMS position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.| GMS vs. Quanex Building Products | GMS vs. Apogee Enterprises | GMS vs. Azek Company | GMS vs. Beacon Roofing Supply |
| CERo Therapeutics vs. Sun Peak Metals | CERo Therapeutics vs. Western Digital | CERo Therapeutics vs. Stratasys | CERo Therapeutics vs. East Africa Metals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |